Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

EXPO vs FCN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
EXPO
Exponent, Inc.

Consulting Services

IndustrialsNASDAQ • US
Market Cap$3.12B
5Y Perf.-14.5%
FCN
FTI Consulting, Inc.

Consulting Services

IndustrialsNYSE • US
Market Cap$4.87B
5Y Perf.+34.4%

EXPO vs FCN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
EXPO logoEXPO
FCN logoFCN
IndustryConsulting ServicesConsulting Services
Market Cap$3.12B$4.87B
Revenue (TTM)$582M$3.87B
Net Income (TTM)$106M$267M
Gross Margin40.1%31.8%
Operating Margin20.6%10.2%
Forward P/E30.9x17.3x
Total Debt$83M$590M
Cash & Equiv.$222M$265M

EXPO vs FCNLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

EXPO
FCN
StockMay 20May 26Return
Exponent, Inc. (EXPO)10085.5-14.5%
FTI Consulting, Inc. (FCN)100134.4+34.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: EXPO vs FCN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: EXPO leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. FTI Consulting, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
EXPO
Exponent, Inc.
The Income Pick

EXPO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 13 yrs, beta 0.89, yield 1.9%
  • Rev growth 4.2%, EPS growth -1.9%, 3Y rev CAGR 4.3%
  • Lower volatility, beta 0.89, Low D/E 21.2%, current ratio 2.40x
Best for: income & stability and growth exposure
FCN
FTI Consulting, Inc.
The Long-Run Compounder

FCN is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 294.4% 10Y total return vs EXPO's 186.1%
  • PEG 2.23 vs EXPO's 5.18
  • Beta 0.09, current ratio 1.56x
Best for: long-term compounding and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthEXPO logoEXPO4.2% revenue growth vs FCN's 2.4%
ValueFCN logoFCNLower P/E (17.3x vs 30.9x), PEG 2.23 vs 5.18
Quality / MarginsEXPO logoEXPO18.2% margin vs FCN's 6.9%
Stability / SafetyFCN logoFCNBeta 0.09 vs EXPO's 0.89
DividendsEXPO logoEXPO1.9% yield; 13-year raise streak; the other pay no meaningful dividend
Momentum (1Y)FCN logoFCN-2.0% vs EXPO's -13.6%
Efficiency (ROA)EXPO logoEXPO13.7% ROA vs FCN's 7.6%, ROIC 36.3% vs 15.9%

EXPO vs FCN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

EXPOExponent, Inc.
FY 2025
Engineering And Other Scientific
84.9%$494M
Environmental And Health
15.1%$88M
FCNFTI Consulting, Inc.
FY 2025
Corporate Finance Segment
40.9%$1.6B
Forensic And Litigation Consulting
20.2%$765M
Economic Consulting
19.0%$721M
Strategic Communications
10.0%$378M
Technology
9.9%$374M

EXPO vs FCN — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLEXPOLAGGINGFCN

Income & Cash Flow (Last 12 Months)

EXPO leads this category, winning 5 of 6 comparable metrics.

FCN is the larger business by revenue, generating $3.9B annually — 6.7x EXPO's $582M. EXPO is the more profitable business, keeping 18.2% of every revenue dollar as net income compared to FCN's 6.9%.

MetricEXPO logoEXPOExponent, Inc.FCN logoFCNFTI Consulting, I…
RevenueTrailing 12 months$582M$3.9B
EBITDAEarnings before interest/tax$125M$445M
Net IncomeAfter-tax profit$106M$267M
Free Cash FlowCash after capex$122M$318M
Gross MarginGross profit ÷ Revenue+40.1%+31.8%
Operating MarginEBIT ÷ Revenue+20.6%+10.2%
Net MarginNet income ÷ Revenue+18.2%+6.9%
FCF MarginFCF ÷ Revenue+21.0%+8.2%
Rev. Growth (YoY)Latest quarter vs prior year+7.8%+9.5%
EPS Growth (YoY)Latest quarter vs prior year+6.5%+4.0%
EXPO leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

FCN leads this category, winning 6 of 7 comparable metrics.

At 19.6x trailing earnings, FCN trades at a 36% valuation discount to EXPO's 30.6x P/E. Adjusting for growth (PEG ratio), FCN offers better value at 2.53x vs EXPO's 5.15x — a lower PEG means you pay less per unit of expected earnings growth.

MetricEXPO logoEXPOExponent, Inc.FCN logoFCNFTI Consulting, I…
Market CapShares × price$3.1B$4.9B
Enterprise ValueMkt cap + debt − cash$3.0B$5.2B
Trailing P/EPrice ÷ TTM EPS30.65x19.64x
Forward P/EPrice ÷ next-FY EPS est.30.87x17.32x
PEG RatioP/E ÷ EPS growth rate5.15x2.53x
EV / EBITDAEnterprise value multiple22.99x11.21x
Price / SalesMarket cap ÷ Revenue5.37x1.29x
Price / BookPrice ÷ Book value/share8.33x3.07x
Price / FCFMarket cap ÷ FCF25.54x31.13x
FCN leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

EXPO leads this category, winning 8 of 8 comparable metrics.

EXPO delivers a 25.5% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $15 for FCN. EXPO carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to FCN's 0.34x. On the Piotroski fundamental quality scale (0–9), EXPO scores 6/9 vs FCN's 5/9, reflecting solid financial health.

MetricEXPO logoEXPOExponent, Inc.FCN logoFCNFTI Consulting, I…
ROE (TTM)Return on equity+25.5%+15.1%
ROA (TTM)Return on assets+13.7%+7.6%
ROICReturn on invested capital+36.3%+15.9%
ROCEReturn on capital employed+19.2%+16.0%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage0.21x0.34x
Net DebtTotal debt minus cash-$139M$324M
Cash & Equiv.Liquid assets$222M$265M
Total DebtShort + long-term debt$83M$590M
Interest CoverageEBIT ÷ Interest expense28.20x
EXPO leads this category, winning 8 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

FCN leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in FCN five years ago would be worth $11,256 today (with dividends reinvested), compared to $7,147 for EXPO. Over the past 12 months, FCN leads with a -2.0% total return vs EXPO's -13.6%. The 3-year compound annual growth rate (CAGR) favors FCN at -2.8% vs EXPO's -8.9% — a key indicator of consistent wealth creation.

MetricEXPO logoEXPOExponent, Inc.FCN logoFCNFTI Consulting, I…
YTD ReturnYear-to-date-9.1%-5.0%
1-Year ReturnPast 12 months-13.6%-2.0%
3-Year ReturnCumulative with dividends-24.4%-8.2%
5-Year ReturnCumulative with dividends-28.5%+12.6%
10-Year ReturnCumulative with dividends+186.1%+294.4%
CAGR (3Y)Annualised 3-year return-8.9%-2.8%
FCN leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

FCN leads this category, winning 2 of 2 comparable metrics.

FCN is the less volatile stock with a 0.09 beta — it tends to amplify market swings less than EXPO's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FCN currently trades 85.5% from its 52-week high vs EXPO's 77.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricEXPO logoEXPOExponent, Inc.FCN logoFCNFTI Consulting, I…
Beta (5Y)Sensitivity to S&P 5000.89x0.09x
52-Week HighHighest price in past year$81.95$189.30
52-Week LowLowest price in past year$63.25$149.31
% of 52W HighCurrent price vs 52-week peak+77.4%+85.5%
RSI (14)Momentum oscillator 0–10038.628.1
Avg Volume (50D)Average daily shares traded452K426K
FCN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

EXPO leads this category, winning 1 of 1 comparable metric.

Wall Street rates EXPO as "Buy" and FCN as "Buy". Consensus price targets imply 34.0% upside for EXPO (target: $85) vs 2.6% for FCN (target: $166). EXPO is the only dividend payer here at 1.89% yield — a key consideration for income-focused portfolios.

MetricEXPO logoEXPOExponent, Inc.FCN logoFCNFTI Consulting, I…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$85.00$166.00
# AnalystsCovering analysts813
Dividend YieldAnnual dividend ÷ price+1.9%
Dividend StreakConsecutive years of raises130
Dividend / ShareAnnual DPS$1.20
Buyback YieldShare repurchases ÷ mkt cap+3.1%+17.6%
EXPO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

EXPO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FCN leads in 3 (Valuation Metrics, Total Returns).

Best OverallExponent, Inc. (EXPO)Leads 3 of 6 categories
Loading custom metrics...

EXPO vs FCN: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is EXPO or FCN a better buy right now?

For growth investors, Exponent, Inc.

(EXPO) is the stronger pick with 4. 2% revenue growth year-over-year, versus 2. 4% for FTI Consulting, Inc. (FCN). FTI Consulting, Inc. (FCN) offers the better valuation at 19. 6x trailing P/E (17. 3x forward), making it the more compelling value choice. Analysts rate Exponent, Inc. (EXPO) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — EXPO or FCN?

On trailing P/E, FTI Consulting, Inc.

(FCN) is the cheapest at 19. 6x versus Exponent, Inc. at 30. 6x. On forward P/E, FTI Consulting, Inc. is actually cheaper at 17. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: FTI Consulting, Inc. wins at 2. 23x versus Exponent, Inc. 's 5. 18x.

03

Which is the better long-term investment — EXPO or FCN?

Over the past 5 years, FTI Consulting, Inc.

(FCN) delivered a total return of +12. 6%, compared to -28. 5% for Exponent, Inc. (EXPO). Over 10 years, the gap is even starker: FCN returned +294. 4% versus EXPO's +186. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — EXPO or FCN?

By beta (market sensitivity over 5 years), FTI Consulting, Inc.

(FCN) is the lower-risk stock at 0. 09β versus Exponent, Inc. 's 0. 89β — meaning EXPO is approximately 890% more volatile than FCN relative to the S&P 500. On balance sheet safety, Exponent, Inc. (EXPO) carries a lower debt/equity ratio of 21% versus 34% for FTI Consulting, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — EXPO or FCN?

By revenue growth (latest reported year), Exponent, Inc.

(EXPO) is pulling ahead at 4. 2% versus 2. 4% for FTI Consulting, Inc. (FCN). On earnings-per-share growth, the picture is similar: FTI Consulting, Inc. grew EPS 5. 5% year-over-year, compared to -1. 9% for Exponent, Inc.. Over a 3-year CAGR, FCN leads at 7. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — EXPO or FCN?

Exponent, Inc.

(EXPO) is the more profitable company, earning 18. 2% net margin versus 7. 1% for FTI Consulting, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXPO leads at 20. 6% versus 10. 9% for FCN. At the gross margin level — before operating expenses — FCN leads at 32. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is EXPO or FCN more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, FTI Consulting, Inc. (FCN) is the more undervalued stock at a PEG of 2. 23x versus Exponent, Inc. 's 5. 18x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, FTI Consulting, Inc. (FCN) trades at 17. 3x forward P/E versus 30. 9x for Exponent, Inc. — 13. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EXPO: 34. 0% to $85. 00.

08

Which pays a better dividend — EXPO or FCN?

In this comparison, EXPO (1.

9% yield) pays a dividend. FCN does not pay a meaningful dividend and should not be held primarily for income.

09

Is EXPO or FCN better for a retirement portfolio?

For long-horizon retirement investors, FTI Consulting, Inc.

(FCN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 09), +294. 4% 10Y return). Both have compounded well over 10 years (FCN: +294. 4%, EXPO: +186. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between EXPO and FCN?

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

EXPO pays a dividend while FCN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

EXPO

Income & Dividend Stock

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 10%
Run This Screen
Stocks Like

FCN

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform EXPO and FCN on the metrics below

Revenue Growth>
%
(EXPO: 7.8% · FCN: 9.5%)
Net Margin>
%
(EXPO: 18.2% · FCN: 6.9%)
P/E Ratio<
x
(EXPO: 30.6x · FCN: 19.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.